Ginkgo BioworksDNA

紐約證券 · USD
8.44
+0.12
(+1.44%)
收盤 11/19 04:59 (UTC+8)
盤後 
8.44 
8.44 
(0.00%)
11/19 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.56
  • 0.89
  • 0.44
  • 0.48
  • 0.60
  • 0.59
  • 0.63
  • 0.19
  • 0.20
  • 0.28
icon
  • 48.13
  • 58.43
  • -50.76
  • 10.20
  • 23.54
  • -0.50
  • 6.76
  • -41.69
  • 3.50
  • 37.48
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q3
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
營業收入淨額
27,711
20,156
19,474
63,411
59,395
59,692
48,318
43,847
89,046
56,206
營業成本
1,8061,7193,09832,87730,20122,77912,0479,62212,00313,721
營業毛利
25,905
18,437
16,376
30,534
29,194
36,913
36,271
34,225
77,043
42,485
營業費用
69,53876,98587,750124,372134,585110,450125,239---
研發費用
40,94546,21049,92050,12769,35353,37070,92376,37777,006134,221
推銷及管理費用
28,59330,77537,83071,60062,57252,59949,04357,29752,29266,285
非經常性項目費用
---2,6452,6604,4815,2734,1572,94964,924
其他營業費用
----------
營業利益
-43,633
-58,548
-71,374
-93,838
-105,391
-73,537
-88,968
-103,606
-55,204
-222,945
其他收入及費用
4,3866,028-4,765-9,7109,8845,307-1,901-4,159-1,5745,954
利息費用
-------94--
稅前純益
-41,255
-57,193
-76,139
-103,548
-95,507
-68,230
-90,869
-107,859
-56,778
-216,991
所得稅
-271128-80-6431-28388-325-375190
稅後純益
-40,984
-46,710
-82,587
-80,751
-80,755
-60,300
-90,957
-107,534
-56,403
-217,181
基本每股稅後盈餘(元)
-0.64-0.75-1.39-1.41-1.45-1.10-1.68-2.00-1.08-0.11
稀釋每股稅後盈餘(元)
-0.62-2.13-1.39-1.42-1.45-2.77-1.68-1.96-1.02-0.11
基本平均股數(千股)
63966.0062094.0059563.0057098.0055633.0054858.0054241.0053814.0052240.002054801.00
稀釋平均股數(千股)
-62094.0059563.0057098.0055633.0054858.0054241.0053814.0052246.002055023.00
還原基本每股稅後盈餘(元)
-0.64-0.75-1.39-1.41-1.45-1.10-1.68-2.00-1.08-4.23
還原稀釋每股稅後盈餘(元)
-0.62-2.13-1.39-1.42-1.45-2.77-1.68-1.96-1.02-4.24
還原基本平均股數(千股)
63,96662,09459,56357,09855,63354,85854,24153,81452,24051,370
還原稀釋平均股數(千股)
-62,09459,56357,09855,63354,85854,24153,81452,24651,375
EBITDA(千元)
-29,037-34,238-69,988-66,987-68,000-44,246-75,503-92,113-39,609-199,661

大家都在看

HOT